Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Cognitive Diagnostics Market Size Forecast: How Large Could The Market Become By 2030?

The cognitive diagnostics market has experienced substantial expansion, with projections indicating a rise from a valuation of $6.25 billion in 2025 to $7.69 billion by 2026, reflecting a commanding compound annual growth rate of 23.1%. This remarkable growth trajectory has been propelled by several key factors, including the escalating incidence of neurodegenerative diseases, a heightened societal focus on maintaining cognitive well-being, advancements in diagnostic imaging technologies, the increasing utilization of uniform cognitive assessment tools, and the proliferation of specialized neurology clinics.

In the realm of cognitive diagnostics, a period of substantial expansion is anticipated in the ensuing years, with the market poised to reach a valuation of $17.46 billion by the year 2030. This impressive trajectory is underpinned by a compound annual growth rate (CAGR) of 22.7%, propelled by several key factors including escalating investments directed towards digital diagnostic solutions, a heightened demand for the identification of cognitive disorders in their nascent stages, the proliferation of assessment tools designed for at-home use, the increasing incorporation of artificial intelligence into clinical decision-making processes, and a pronounced emphasis on tailored cognitive care strategies. Furthermore, prevailing trends shaping this forecast period encompass the growing utilization of AI-powered cognitive assessment instruments, the wider adoption of digital platforms for cognitive screening, a greater deployment of neuroimaging analytics, the expansion of remote cognitive testing capabilities, and an intensified focus on the early detection of diseases.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19373&type=smp

#Cognitive Diagnostics Market Growth Drivers And Industry Catalysts

The burgeoning rates of neurological conditions are poised to act as a significant catalyst for the expansion of the cognitive diagnostics market. These neurological conditions, which impact the brain, spinal cord, and the broader nervous system, lead to functional impairments manifesting as cognitive deterioration, difficulties with motor control, and unusual sensory experiences. A primary factor fueling this increase is the higher occurrence of age-associated ailments, notably Alzheimer’s and Parkinson’s disease. In addition to genetic predispositions, environmental pollutants, elevated stress levels, poor dietary habits, and inactive lifestyles also play a role in the growing prevalence of these disorders. Within the realm of neurological diseases, cognitive diagnostics serve a crucial role in evaluating, identifying, and tracking impairments in cognitive function, thereby facilitating early detection and effective management of conditions such as Alzheimer’s and Parkinson’s. Illustratively, the Alzheimer’s Association, a U.S. nonprofit supporting Alzheimer’s care, assistance, and research, reported in May 2024 that the count of Americans aged 65 and over living with Alzheimer’s dementia climbed from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the escalating incidence of neurological disorders is directly fostering the growth of the cognitive diagnostics market.

Cognitive Diagnostics Market Segment Analysis: What Are The Major Market Categories?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

#Cognitive Diagnostics Market Trends Influencing Long-Term Demand

Leading entities within the cognitive diagnostics sector are prioritizing the delivery of immediate understandings of cognitive well-being, leveraging innovations in diagnostic instruments like neuropsychological testing platforms to elevate the precision, effectiveness, and completeness of cognitive evaluations. These advanced neuropsychological testing platforms serve as sophisticated digital instruments engineered for the appraisal of cognitive capabilities through established testing methodologies, encompassing memory functions, attentional processes, and problem-solving proficiencies. Illustratively, in April of 2024, BrainCheck Inc., a United States-headquartered digital health enterprise dedicated to fostering positive advancements in cognitive health, introduced its all-encompassing digital cognitive assessment framework at the American Academy of Neurology (AAN) Annual Meeting, thereby exhibiting its cutting-edge instruments designated for cognitive screening, thorough assessment, and strategic care design. This particular platform, comprising modules for Assessment, Screening, and Planning, provides healthcare professionals with a contemporary approach to optimizing the management of cognitive health, utilizing mobile technology that guarantees both accuracy and user-friendliness. Such groundbreaking developments are intended to bolster the operational efficiency and the caliber of healthcare services offered to both patients and practitioners by furnishing detailed, research-supported guidance and thorough strategies for patient care.

Cognitive Diagnostics Market Leading Companies Driving Competitive Growth

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Access The Complete Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Cognitive Diagnostics Market Largest Region By Revenue And Market Share

North Americawas the largest region in the cognitive diagnostics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model